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Since the budget of 2006 for NF OTKA proposals was drastically reduced, my NF proposal 
received support of about just 20% of that was planned (that is close to an F  type proposal without 
PD grant). This support was not sufficient to keep any of the aims of the original proposal. 
Therefore, we had to revise our research plan at the start of the research project. Despite all these, 
we, I think, managed to use effectively the support we gained. The research group as well as key 
techniques and critical model systems  were successfully established, as follows: 
Earlier studies have suggested a few PrP segments that are involved in the pro- or anti-
apoptotic effects of PrP , however, a more accurate and detailed mapping of these segments meets 
with substantial technical difficulties. Basically, the answer to this question requires the 
introduction of  mutant and wild type PrP-s to cells (or animals) and then, the measurements of the 
extent of the apoptosis that are induced.  Transgenic animal experiments are restricted by high cost 
and long time investments.  Since wild type PrP rescues the pro-apoptotic phenotype, and thus, 
considerably moderate the experimental outcome, PrP-knock out cell line has to be used in these 
studies. Furthermore, although transient transfections would be preferable over the generation of 
stabile cell lines, the low transfection efficiency that is associated with the neuronal cell lines used 
here makes difficult it to discern the effects of the mutation due to the background caused by the 
non-transfected cell population. The another drawback of the transient expression of mutant PrP-s 
is the very limited time-window for executing the experiments.  In the last years with the help of 
this young OTKA grant we managed to build our lab, set up the needed techniques and develop 
several new methods and  approaches. Some of these developments make it possible to overcome 
on above difficulties. By now, we have PrP-knock out mice (a gift from prof. Agguzi) and neuronal 
cell lines (Hpl, Zpl, generated from the hypocampus of PrP knok out mice) addition to the 
commercially available SH-SY5Y  cells expressing no detectable amount of PrP. We also have set 
up the sleeping beauty transposon/transposase system (SB100) of Zsuzsa Izsvák for the transfection 
of above cells that offers several advantages. The transposase ensures a high integration efficiency 
of the target gene to the genom of the cells (about 70% of the transfected cells express the target 
protein at high level). We envisaged that this high percentages of stable integration allowed us to 
use a transfected cell population for an extended time period without the tedious generation of 
individual clones. Furthermore, since the transposase inserts the entire sequences between the two 
transposon arms, a  practically 100% percent coupling can be established between the expression of 
the target and a marker protein, such as GFP. This allowed us to significantly increase the signal to 
noise ration since the non-transfected cells do not contribute to the background when only the 
green cells population are selected for the measurements. These high percentages coupling were 
experimentally demonstrated by using a sleeping beauty transposon vector where a puromicyn and 
a cherry protein expression cassette were inserted between the transposon arms. After a transfection 
of Zpl cells, the puromicyn selected clones were analysed for red fluorescence. We also set up 
systems (using anexin or Propidium Iodide) for the measurement of apoptosis by FACS in Zpl and 
SH-SY5Y cells transfected by above SB vector system.  
The team made considerable effort to establish an appropriate cell model system for TSE that 
is not available currently on the field. One of our attempts to generate a neuronal cell line with a 
tight inducible expression of PrP-3F4 has failed, since the available inducible expression systems 
were found to be either leaky  or  the expression can not be turned off sufficient rapidly if once it 
was turned on.  
In another approach we set up an expression system in PrP-/- neuronal cell line for the 
expression of mutant PrP and PrP paralogues, such as doppel and shadoo. There is an increasing 
body of evidences that there is a connection between the apoptotic neuronal cell death induced by 
the conformational conversion of PrP during TSE-s and the physiological role of PrP that is likely 
to include a pro- and/or anti-apoptotic function. Shadoo that is an analogue of the N-terminal part 
of PrP has been shown to have an anti-apoptotic function. Doppel that is an analogue of the C-
terminal part of PrP has been shown to have a pro-apoptotic function. The team  uses these protein 
variants for delineating the mechanism of cell death during the progression of TSE. There are 
evidences that PrP molecules form dimers interacting directly. We also proposes that both shadow 
and doppel forms heterodimers with PrP. To study and demonstrate these interactions CFP and 
YFP fusion of these proteins were generated along with YFP-GPI and CFP-GPI, as well as YFP-
CFP-GPI constructs for negative and positive controls, respectively. A bleach out protocol was set 
up with the use of confocal microscopy to measure FRET. 
It is not clear if post-translation modifications contribute to the initiation of the conformational 
transition of PrP. We took part in developing methods for the measurments of the extent of post-
translation modification such as deamidation in proteins. Thus, we have a tool now for following 
such modifications in various mutant PrP molecules. 
We needed also methods for the effective folding of various mutants of PrP. To this end, a 
generally-applicable method was developed in our lab in collaboration with two research groups at 
Cornell for effective screening of oxidative folding conditions that promote the regeneration of 
disulfide-bond-containing proteins. The method is so powerful that could be effectively used in 
high throughput applications and was published in Nature Biotechnology. 
